European Union - English - EMA (European Medicines Agency)

dipharma arzneimittel gmbh - miglustat - gaucher disease - other alimentary tract and metabolism products - miglustat dipharma is indicated for the oral treatment of adult patients with mild to moderate type 1 gaucher disease.miglustat dipharma may be used only in the treatment of patients for whom enzyme replacement therapy is unsuitable.miglustat dipharma is indicated for the treatment of progressive neurological manifestations in adult patients and paediatric patients with niemann-pick type c disease.

European Union - English - EMA (European Medicines Agency)

dipharma arzneimittel gmbh - sapropterin dihydrochloride - phenylketonurias - other alimentary tract and metabolism products, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment.sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.

Ireland - English - HPRA (Health Products Regulatory Authority)

dipharma arzneimittel gmbh - nitisinone - capsule, hard - nitisinone

Ireland - English - HPRA (Health Products Regulatory Authority)

dipharma arzneimittel gmbh - nitisinone - capsule, hard - nitisinone

Ireland - English - HPRA (Health Products Regulatory Authority)

dipharma arzneimittel gmbh - nitisinone - capsule, hard - nitisinone